{"@type":"Dataset","integmet_study":"MTBLS423","mesh_chemical_id":["https://identifiers.org/mesh:D013433","https://identifiers.org/mesh:D013107","https://identifiers.org/mesh:D002518","https://identifiers.org/mesh:D013109"],"mesh_chemical_pubtator_kw":["sulfatide","Sphingolipid","sphingolipid","ceramide","sphingomyelin"],"mesh_disease_id":["https://identifiers.org/mesh:D008659","https://identifiers.org/mesh:D002318","https://identifiers.org/mesh:D003924","https://identifiers.org/mesh:D009765"],"mesh_disease_pubtator_kw":["metabolic diseases","cardiovascular disease","type 2 diabetes","obesity"],"source_id":"https://identifiers.org/metabolights:MTBLS423","study_findings":"Decreased sphingolipid metabolites linked to improved HbA1c after intervention.","study_observation":"Metabolic signatures in prepubertal children with obesity.","study_summary":"Lifestyle intervention affects sphingolipid metabolism in obese children.","study_title_original":"Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity"}